MED-ANASTROZOLE TABLET

Země: Kanada

Jazyk: angličtina

Zdroj: Health Canada

Aktivní složka:

ANASTROZOLE

Dostupné s:

GENERIC MEDICAL PARTNERS INC

ATC kód:

L02BG03

INN (Mezinárodní Name):

ANASTROZOLE

Dávkování:

1MG

Léková forma:

TABLET

Složení:

ANASTROZOLE 1MG

Podání:

ORAL

Jednotky v balení:

30

Druh předpisu:

Prescription

Terapeutické oblasti:

ANTINEOPLASTIC AGENTS

Přehled produktů:

Active ingredient group (AIG) number: 0128681001; AHFS:

Stav Autorizace:

APPROVED

Datum autorizace:

2012-10-25

Charakteristika produktu

_MED-ANASTROZOLE_
_ _
_Product Monograph _
_Page 1 of 56_
_ _
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
PR
MED-ANASTROZOLE
Anastrozole tablets
Tablet 1 mg, Oral use
Professed
Non-Steroidal Aromatase Inhibitor
Generic Medical Partners Inc.
1500 Don Mills Road, Suite 711
Toronto, Ontario
M3B 3K4
Date of Initial Authorization:
OCT 25, 2012
Date of Revision:
APR 26, 2023
Submission Control Number: 270891
_MED-ANASTROZOLE_
_ _
_Product Monograph _
_Page 2 of 56_
_ _
RECENT MAJOR LABEL CHANGES
7 WARNINGS AND PRECAUTIONS
04/2023
TABLE OF CONTENTS
RECENT MAJOR LABEL CHANGES
....................................................................................................
2
TABLE OF CONTENTS
..........................................................................................................................
2
PART I: HEALTH PROFESSIONAL INFORMATION
............................................................................
4
1
INDICATIONS
.............................................................................................................................
4
1.1
Pediatrics
..........................................................................................................................
4
1.2
Geriatrics
...........................................................................................................................
4
2
CONTRAINDICATIONS
.............................................................................................................
4
3
SERIOUS WARNINGS AND PRECAUTIONS BOX
.................................................................. 4
4
DOSAGE AND ADMINISTRATION
............................................................................................
4
4.2
Recommended Dose and Dosage Adjustment
................................................................. 4
4.4
Administration
...................................................................................................................
5
4.5
Missed Dose
...........................................